Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
Saved in:
| Title: | Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study. |
|---|---|
| Authors: | Frenck RW Jr; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA. Electronic address: robert.frenck@cchmc.org., Naficy A; PATH, Seattle, WA, USA., Feser J; PATH, Seattle, WA, USA., Dickey MP; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, USA., Leyva-Grado VH; Auro Vaccines, Pearl River, NY, USA., Egan MA; Auro Vaccines, Pearl River, NY, USA., Chen T; Auro Vaccines, Pearl River, NY, USA., Eldridge JH; Auro Vaccines, Pearl River, NY, USA., Sciotto-Brown S; Auro Vaccines, Pearl River, NY, USA., Hermida L; Auro Vaccines, Pearl River, NY, USA., Promeneur D; Auro Vaccines, Pearl River, NY, USA., Luckay A; Auro Vaccines, Pearl River, NY, USA., Medina H; Auro Vaccines, Pearl River, NY, USA., Lazaro GA; Auro Vaccines, Pearl River, NY, USA., Patel NR; Auro Vaccines, Pearl River, NY, USA., Naqvi T; Auro Vaccines, Pearl River, NY, USA., Broder CC; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Dimitrov AS; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, USA., Gast C; PATH, Seattle, WA, USA., Mercer LD; PATH, Seattle, WA, USA., Raine M; PATH, Seattle, WA, USA., Andi-Lolo I; PATH, Seattle, WA, USA., Innis BL; PATH, Seattle, WA, USA., Aponte JJ; PATH, Seattle, WA, USA., Hamm S; Auro Vaccines, Pearl River, NY, USA., Rathi N; PATH, India. |
| Source: | Lancet (London, England) [Lancet] 2025 Dec 13; Vol. 406 (10521), pp. 2792-2803. Date of Electronic Publication: 2025 Nov 14. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
